Christopher P. Cannon
Christopher P. Cannon
Professor of Medicine, Harvard Medical School
Verified email at
Cited by
Cited by
Third universal definition of myocardial infarction
JJ Bax, H Baumgartner, C Ceconi, V Dean, R Fagard, C Funck-Brentano, ...
Journal of the American College of Cardiology 60 (16), 1581-1598, 2012
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
L Wallentin, RC Becker, A Budaj, CP Cannon, H Emanuelsson, C Held, ...
New England Journal of Medicine 361 (11), 1045-1057, 2009
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon, E Braunwald, CH McCabe, DJ Rader, JL Rouleau, R Belder, ...
New England journal of medicine 350 (15), 1495-1504, 2004
Ezetimibe added to statin therapy after acute coronary syndromes
CP Cannon, MA Blazing, RP Giugliano, A McCagg, JA White, P Theroux, ...
New England Journal of Medicine 372 (25), 2387-2397, 2015
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
EM Antman, MJ Tanasijevic, B Thompson, M Schactman, CH McCabe, ...
New England Journal of Medicine 335 (18), 1342-1349, 1996
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
CP Cannon, WS Weintraub, LA Demopoulos, R Vicari, MJ Frey, N Lakkis, ...
New England Journal of Medicine 344 (25), 1879-1887, 2001
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
N Engl j Med 369, 1327-1335, 2013
C-reactive protein levels and outcomes after statin therapy
PM Ridker, CP Cannon, D Morrow, N Rifai, LM Rose, CH McCabe, ...
New England Journal of Medicine 352 (1), 20-28, 2005
Predictors of hospital mortality in the global registry of acute coronary events
CB Granger, RJ Goldberg, O Dabbous, KS Pieper, KA Eagle, CP Cannon, ...
Archives of internal medicine 163 (19), 2345-2353, 2003
TIMI frame count: a quantitative method of assessing coronary artery flow
CM Gibson, CP Cannon, WL Daley, JT Dodge Jr, B Alexander, SJ Marble, ...
Circulation 93 (5), 879-888, 1996
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
JA De Lemos, DA Morrow, JH Bentley, T Omland, MS Sabatine, ...
New England Journal of Medicine 345 (14), 1014-1021, 2001
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
CP Cannon, CM Gibson, CT Lambrew, DA Shoultz, D Levy, WJ French, ...
Jama 283 (22), 2941-2947, 2000
Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial
MJ Price, PB Berger, PS Teirstein, JF Tanguay, DJ Angiolillo, D Spriggs, ...
Jama 305 (11), 1097-1105, 2011
Clopidogrel with or without omeprazole in coronary artery disease
DL Bhatt, BL Cryer, CF Contant, M Cohen, A Lanas, TJ Schnitzer, ...
New England Journal of Medicine 363 (20), 1909-1917, 2010
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy
DA Morrow, N Rifai, EM Antman, DL Weiner, CH McCabe, CP Cannon, ...
Journal of the American College of Cardiology 31 (7), 1460-1465, 1998
SD Wiviott, D Trenk, AL Frelinger, M O’Donoghue, FJ Neumann, ...
Circulation 116 (25), 2923-2932, 2007
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
CM Gibson, CP Cannon, SA Murphy, KA Ryan, R Mesley, SJ Marble, ...
Circulation 101 (2), 125-130, 2000
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ...
Jama 304 (16), 1821-1830, 2010
The system can't perform the operation now. Try again later.
Articles 1–20